Metraipolis › archive › dc_addf72769603
Fc-engineering for improved cancer immunotherapy — Europe PMC PMID:42621748
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42621748
- DOI
- 10.1042/bst20250554
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T09:10:08.571Z
- SHA-256 of the archived text
135b6c126dd39ae6167e8ec11aaabe0b5c1b0ff6a9e79306c67083a69f4b603d- Stable URL of this page
https://metraipolis.com/documento/dc_addf72769603
How to cite
Fc-engineering for improved cancer immunotherapy — Europe PMC PMID:42621748 — Europe PMC (en), https://europepmc.org/article/MED/42621748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_addf72769603 (Metraipolis archive dc_addf72769603, sha256 135b6c126dd39ae6167e8ec11aaabe0b5c1b0ff6a9e79306c67083a69f4b603d)
BibTeX
@misc{dcaddf72769603,
title = {Fc-engineering for improved cancer immunotherapy — Europe PMC PMID:42621748},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42621748},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_addf72769603; sha256 135b6c126dd39ae6167e8ec11aaabe0b5c1b0ff6a9e79306c67083a69f4b603d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42621748. Agents can read the archived copy with the MCP tool read_document.